Peregrine Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $724K | Hold |
|
|||||
|
2025
Q2 | $604K | Sell |
|
|||||
|
2025
Q1 | $889K | Hold |
|
|||||
|
2024
Q4 | $1.3M | Hold |
|
|||||
|
2024
Q3 | $1.19M | Buy |
|
|||||
|
2024
Q2 | $962K | Hold |
|
|||||
|
2024
Q1 | $1.16M | Hold |
|
|||||
|
2023
Q4 | $1.03M | Sell |
|
|||||
|
2023
Q3 | $1.27M | Sell |
|
|||||
|
2023
Q2 | $1.62M | Buy |
|
|||||
|
2023
Q1 | $1.23M | Sell |
|
|||||
|
2022
Q4 | $1.1M | Hold |
|
|||||
|
2022
Q3 | $1.15M | Hold |
|
|||||
|
2022
Q2 | $1.42M | Hold |
|
|||||
|
2022
Q1 | $1.93M | Hold |
|
|||||
|
2021
Q4 | $2.2M | Hold |
|
|||||
|
2021
Q3 | $1.99M | Hold |
|
|||||
|
2021
Q2 | $1.68M | Hold |
|
|||||
|
2021
Q1 | $1.32M | Hold |
|
|||||
|
2020
Q4 | $1.33M | Buy |
|